Detection of Mycoplasma pneumoniae , Chlamydia pneumoniae , and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay
Abstract A multiplex real-time PCR assay for the detection of Mycoplasma pneumoniae (MP181), Chlamydia ( Chlamydophila ) pneumoniae (CP-Arg), Legionella spp. (Pan-Leg), and the human RNase P (RNase P) gene was developed for rapid testing of atypical bacterial respiratory pathogens in clinical specim...
Saved in:
Published in | Diagnostic microbiology and infectious disease Vol. 70; no. 1; pp. 1 - 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.05.2011
Elsevier Elsevier Biomedical |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract A multiplex real-time PCR assay for the detection of Mycoplasma pneumoniae (MP181), Chlamydia ( Chlamydophila ) pneumoniae (CP-Arg), Legionella spp. (Pan-Leg), and the human RNase P (RNase P) gene was developed for rapid testing of atypical bacterial respiratory pathogens in clinical specimens. This method uses 4 distinct hydrolysis probes to detect 3 leading causes of community-acquired pneumonia. The assay was evaluated for specificity and sensitivity by testing against 35 related organisms, a dilution series of each specific target and 197 clinical specimens. Specificity testing demonstrated no cross-reactivity. A comparison to previously validated singleplex real-time PCR assays for each agent was also performed. The analytical sensitivity for specific pathogen targets in both the singleplex and multiplex was identical (50 fg), while efficiencies ranged from 82% to 97% for the singleplex assays and from 90% to 100% for the multiplex assay. The clinical sensitivity of the multiplex assay was improved for the Pan-Leg and CP-Arg targets when compared to the singleplex. The MP181 assay displayed equivalent performance. This multiplex assay provides an overall improvement in the diagnostic capability for these agents by demonstrating a sensitive, high-throughput and rapid method. This procedure may allow for a practical and efficient means to test respiratory clinical specimens for atypical pneumonia agents in health care settings and facilitate an appropriate public health response to outbreaks. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally to the writing of the manuscript. |
ISSN: | 0732-8893 1879-0070 |
DOI: | 10.1016/j.diagmicrobio.2010.11.014 |